In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing
NOW WHAT
The most obvious problem is poor nutritional intake with inadequate levels of protein
While the mechanistic data for how LDN and these specific peptides work is strong and growing, large-scale, double-blind clinical trials for their combined use in Hashimotos are still lacking
Sleep sets the base layer
The SURPASS-2 trial (Frias et al., NEJM , 2021) directly compared tirzepatide to semaglutide 1 mg in patients with type 2 diabetes and found tirzepatide superior across all dose levels for both weight loss and glycemic control